3rdGO

3rdGO Innovative Engineering Platform

3rdGO therapeutic agents are targeted immunotherapeutic agents that have been modified from a bispecific antibody platform.

3rdGO addresses the most important aspects of the humoral (antibody) response against cancer namely:

• More specific responses and less side effects
• Safer and more controlled responses with less fatality rate
• Better connectivity between immune cells and cancer cells even for solid tumors where better efficacy and sustainability could be facilitated

As a result:

• Reduces likelihood of cancer relapse
• Immune cells are more likely to reach the tumor site
• Ability to bypass tumor’s evasion mechanism
• Regulator molecule to prevent excessive immune response